Filing Details

Accession Number:
0000711377-19-000054
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-12 16:00:34
Reporting Period:
2019-11-08
Accepted Time:
2019-11-12 16:00:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-08 20,000 $63.86 227,311 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 186,970 Direct
Footnotes
  1. The shares were sold under the terms of a Rule 10b5-1 plan filed by the Reporting Person on October 1, 2019
  2. There are 180,209 shares remaining in LLCs in which Mr Herbert and his spouse have minority financial positions. Mr. and Mrs. Herbert own 39,568 shares jointly, 7,434 shares are held in trust for Mrs. Herbert, and 100 shares are held in a charitable remainder trust in which r. Herbert and his spouse are trustees and beneficiaries.